Disease | Financial Buzz

Healthcare Investing News Market News Technology The Market Buzz

Blue Water Vaccines Reports Exploration of its VLP Platform for use in Monkeypox Vaccine Candidate

David Kim08/17/2022

20237

Blue Water Vaccines Inc. (NASDAQ: BWV) reported that the company plans to explore potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform. ...

Healthcare Investing News Market News Technology The Market Buzz

Plus Therapeutics Reports Share Repurchase Program

David Kim08/15/2022

18187

Plus Therapeutics, Inc. (NASDAQ: PSTV) has announced that its board of directors has approved a share repurchase program with authorization to repurchase up to USD 2 Million of the...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Addex Pharmaceuticals (NASDAQ: ADXN) Terminates Dipraglurant Phase 2b/3 Study

financial buzz06/17/2022

16891

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Addex Pharmaceuticals Terminates Dipraglurant Phase 2b/3 Study” Addex Therapeutics Ltd (NASDAQ: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Adagio Therapeutics Reports ADG20 as First Monoclonal Antibody to Meet Primary Endpoints for Treatment of COVID-19

Andy Liao03/30/2022

17439

Adagio Therapeutics, Inc. (NASDAQ: ADGI) reports primary endpoints were met with statistical significance for all three indications of the company’s ongoing Phase 2/3 clinical trials evaluating its drug adintrevimab...

Tag: Disease

Blue Water Vaccines Reports Exploration of its VLP Platform for use in Monkeypox Vaccine Candidate

Plus Therapeutics Reports Share Repurchase Program

“The Buzz” Show: Addex Pharmaceuticals (NASDAQ: ADXN) Terminates Dipraglurant Phase 2b/3 Study

Adagio Therapeutics Reports ADG20 as First Monoclonal Antibody to Meet Primary Endpoints for Treatment of COVID-19

ABOUT US

Tweets